View Document Preview and Link Open Document File Size: 868,09 KB Share Result on Facebook
City Boston / / Company Becton / Dickinson and Company / Wellman / Sagent Pharmaceuticals / BioMed Central Ltd. / Reversed Phase / Microbiology Labs / Creative Commons / / Country France / United States / / Currency USD / / / Event FDA Phase / / Facility Massachusetts General Hospital / Laboratory Standards Institute / / IndustryTerm probe solution / increase healthcare costs / μl antibiotic 4X stock solution / instrument software / p-methoxybenzyl protection / mM antibiotic solution / 2X stock solution / / MedicalCondition Pseudomonas / strain / soft-tissue infections / high-inoculum staphylococcal endocarditis infections / skin infections / severe infections / nosocomial infections / infections / Methicillin Susceptible S. aureus / infective endocarditis / bacteremia / bacterial infections / MSSA infections / Resistant infections / treatment failures/prolonged illness / S. aureus / cefazolin antibiotic susceptibility/activity determination S. aureus / Klebsiella pneumonia / β-lactamase resistance S. aureus / Methicillin Resistant S. aureus / selected S. aureus / / MedicalTreatment antibiotics / antibiotic therapy / / MusicGroup Reversed / Liquid / / Organization Harvard Medical School / Clinical and Laboratory Standards Institute / Massachusetts General Hospital / Statens Serum Institut / Wellman Centre for Photomedicine / / Person Robert L. Skov / Marcy l’Etoile / Mary Jane Ferraro / M.J. Ferraro / / / Position β-lactamase producer / producer / author / representative / reporter / / Product cefazolin / penicillin / cefoxitin / Bacterial antibiotic / / ProvinceOrState Texas / New Jersey / Virginia / Illinois / Massachusetts / / Technology gene expression / genotype / / URL http / SocialTag 
In Silico identification of pathogenic strains of Cronobacter from Biochemical data reveals association of inositol fermentation with pathogenicity